The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action
![Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day - Oncology Nurse Advisor Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day - Oncology Nurse Advisor](https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2019/01/lungg639617820rot_1368717.jpg)
Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day - Oncology Nurse Advisor
![Frontiers | A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer Frontiers | A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer](https://www.frontiersin.org/files/MyHome%20Article%20Library/478981/478981_Thumb_400.jpg)
Frontiers | A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma
![Biology | Free Full-Text | Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist Biology | Free Full-Text | Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist](https://www.mdpi.com/biology/biology-10-00069/article_deploy/html/images/biology-10-00069-g001.png)
Biology | Free Full-Text | Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist
Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-L
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma
![The Role of Pemetrexed in the Pharmacotherapy of Malignant Pleural Mesothelioma - P.A. Zucali, F. De Vincenzo, M. Simonelli, E. Lorenzi, M. Perrino, A. Santoro, 2010 The Role of Pemetrexed in the Pharmacotherapy of Malignant Pleural Mesothelioma - P.A. Zucali, F. De Vincenzo, M. Simonelli, E. Lorenzi, M. Perrino, A. Santoro, 2010](https://journals.sagepub.com/cms/10.4137/CMT.S1166/asset/images/large/10.4137_cmt.s1166-fig2.jpeg)
The Role of Pemetrexed in the Pharmacotherapy of Malignant Pleural Mesothelioma - P.A. Zucali, F. De Vincenzo, M. Simonelli, E. Lorenzi, M. Perrino, A. Santoro, 2010
![Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer | Business Wire Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer | Business Wire](https://mms.businesswire.com/media/20220531005701/en/1471357/5/PEMEtrexed.jpg)
Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer | Business Wire
![Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7c7f608f323311f1df8893e48d314b8cf2c92507/2-Figure1-1.png)
Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar
![Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | British Journal of Cancer Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603995/MediaObjects/41416_2007_Article_BF6603995_Fig1_HTML.gif)